RPAM
SRNE

Rhenman & Partners Asset Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Rhenman & Partners Asset Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-72,535
Closed -$328K – 99
2014
Q3 		$328K Hold
72,535
– – 0.1% 97
2014
Q2 		$490K Buy
72,535
+23,400
+48% +$158K 0.15% 92
2014
Q1 		$630K Buy
+49,135
New +$630K 0.19% 86